The vaccine induced FAP-specific CD8+ T-cells, leading to a reduction in the number of FAPα+ cells, immunosuppressive cells (MDSCs and Tregs), and an alteration in the tumor cytokine environment (reduction of IL-4, IL-10, TGF-β). The gene discussed is TGFB1; the disease is neoplasm.